TrialRMD open2022

Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis.

Chun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.